Literature DB >> 31062157

Preoperative biliary drainage of the hepatic lobe to be resected does not affect liver hypertrophy after percutaneous transhepatic portal vein embolization.

Shin Miura1, Atsushi Kanno2, Koji Fukase3, Yu Tanaka2, Ryotaro Matsumoto2, Tatsuhide Nabeshima2, Seiji Hongou2, Tetsuya Takikawa2, Shin Hamada2, Kiyoshi Kume2, Kazuhiro Kikuta2, Kei Nakagawa4, Michiaki Unno4, Atsushi Masamune2.   

Abstract

BACKGROUND: In patients with malignant perihilar biliary strictures, preoperative biliary drainage (PBD) of the hepatic lobe to be resected may decrease the liver volume of the future liver remnant (FLR) after percutaneous transhepatic portal vein embolization (PVE). However, evidence of its application is insufficient. This study aimed to clarify the effects of PBD on liver hypertrophy after PVE.
METHODS: Between January 2008 and December 2017, 169 patients with malignant perihilar biliary strictures underwent major hepatectomy or palliative surgery at our hospital. Of these, 76 patients who underwent PVE were categorized into two groups: group A (n = 29) who received unilateral PBD of the FLR and group B (n = 47) who received bilateral PBD, including that of the hepatic lobe to be resected. FLR ratios after PVE and liver hypertrophy ratios were retrospectively compared in both groups.
RESULTS: Group B exhibited significantly severe biliary stenosis (p = 0.0038) and high serum bilirubin before biliary drainage (p = 0.0037). After PVE, the total liver volumes were 1287 ± 260 ml and 1340 ± 257 ml (p = 0.39), respectively. FLR volumes were 555 ± 135 and 577 ± 113 ml (p = 0.45), respectively. FLR ratios were 43.4 ± 8.2% and 43.4 ± 6.4%, respectively (p = 0.98). Liver hypertrophy ratios were 124.2 ± 17.7% and 129.2 ± 20.9%, respectively (p = 0.28). In addition, an examination which excluded patients with Bismuth type I obtained similar result.
CONCLUSIONS: PBD of the hepatic lobe to be resected did not decrease the FLR ratios and hypertrophy ratios. Thus, in patients with poor biliary drainage, additional PBD of the target lobe is acceptable.

Entities:  

Keywords:  Cholangiocarcinoma; Endoscopic retrograde cholangiopancreatography and biliary drainage; Gallbladder carcinoma; Hepatectomy; Obstructive jaundice

Mesh:

Year:  2019        PMID: 31062157     DOI: 10.1007/s00464-019-06813-y

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  20 in total

1.  Selective versus total biliary drainage for obstructive jaundice caused by a hepatobiliary malignancy.

Authors:  Takeaki Ishizawa; Kiyoshi Hasegawa; Keiji Sano; Hiroshi Imamura; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Am J Surg       Date:  2007-02       Impact factor: 2.565

Review 2.  Percutaneous vs. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma - a systematic review and meta-analysis.

Authors:  Ahmer Hameed; Tony Pang; Judy Chiou; Henry Pleass; Vincent Lam; Michael Hollands; Emma Johnston; Arthur Richardson; Lawrence Yuen
Journal:  HPB (Oxford)       Date:  2016-04-04       Impact factor: 3.647

3.  Bismuth classification is associated with the requirement for multiple biliary drainage in preoperative patients with malignant perihilar biliary stricture.

Authors:  Shin Miura; Atsushi Kanno; Atsushi Masamune; Shin Hamada; Tetsuya Takikawa; Eriko Nakano; Naoki Yoshida; Seiji Hongo; Kazuhiro Kikuta; Kiyoshi Kume; Morihisa Hirota; Hiroshi Yoshida; Yu Katayose; Michiaki Uuno; Tooru Shimosegawa
Journal:  Surg Endosc       Date:  2014-10-03       Impact factor: 4.584

4.  Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial.

Authors:  Robert J S Coelen; Eva Roos; Jimme K Wiggers; Marc G Besselink; Carlijn I Buis; Olivier R C Busch; Cornelis H C Dejong; Otto M van Delden; Casper H J van Eijck; Paul Fockens; Dirk J Gouma; Bas Groot Koerkamp; Michiel W de Haan; Jeanin E van Hooft; Jan N M IJzermans; G Matthijs Kater; Jan J Koornstra; Krijn P van Lienden; Adriaan Moelker; Steven W M Olde Damink; Jan-Werner Poley; Robert J Porte; Rogier J de Ridder; Joanne Verheij; Victor van Woerden; Erik A J Rauws; Marcel G W Dijkgraaf; Thomas M van Gulik
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-08-17

Review 5.  Risk factors for post-ERCP pancreatitis: A systematic review and meta-analysis.

Authors:  Xiang Ding; FuCheng Zhang; YaoJun Wang
Journal:  Surgeon       Date:  2014-12-24       Impact factor: 2.392

6.  Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients.

Authors:  Gennaro Nuzzo; Felice Giuliante; Francesco Ardito; Ivo Giovannini; Luca Aldrighetti; Giulio Belli; Fabrizio Bresadola; Fulvio Calise; Raffaele Dalla Valle; Davide F D'Amico; Leandro Gennari; Stefano M Giulini; Alfredo Guglielmi; Elio Jovine; Riccardo Pellicci; Heinrich Pernthaler; Antonio D Pinna; Stefano Puleo; Guido Torzilli; Lorenzo Capussotti; Umberto Cillo; Giorgio Ercolani; Massimo Ferrucci; Laura Mastrangelo; Nazario Portolani; Carlo Pulitanò; Dario Ribero; Andrea Ruzzenente; Vincenzo Scuderi; Bruno Federico
Journal:  Arch Surg       Date:  2012-01

7.  Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.

Authors:  Sung Gyu Lee; Gi Won Song; Shin Hwang; Tae Yong Ha; Deok Bog Moon; Dong Hwan Jung; Ki Hun Kim; Chul Soo Ahn; Myung Hwan Kim; Sung Koo Lee; Kyu Bo Sung; Gi Young Ko
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-10-23       Impact factor: 7.027

8.  Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization.

Authors:  M Nagino; Y Nimura; J Kamiya; S Kondo; K Uesaka; Y Kin; N Hayakawa; H Yamamoto
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

9.  Portal vein embolization before right hepatectomy: prospective clinical trial.

Authors:  Olivier Farges; Jacques Belghiti; Reza Kianmanesh; Jean Marc Regimbeau; Roberto Santoro; Valérie Vilgrain; Alban Denys; Alain Sauvanet
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

10.  Predictability of 99mTc-Galactosyl Human Serum Albumin Scintigraphy for Posthepatectomy Liver Failure.

Authors:  Ayako Kato; Yuji Nakamoto; Takayoshi Ishimori; Satoru Seo; Shinji Uemoto; Kaori Togashi
Journal:  AJR Am J Roentgenol       Date:  2017-10-12       Impact factor: 3.959

View more
  4 in total

Review 1.  Imaging-guided interventions modulating portal venous flow: Evidence and controversies.

Authors:  Roberto Cannella; Lambros Tselikas; Fréderic Douane; François Cauchy; Pierre-Emmanuel Rautou; Rafael Duran; Maxime Ronot
Journal:  JHEP Rep       Date:  2022-04-04

2.  The Interplay Between Biliary Occlusion and Liver Regeneration: Repeated Regeneration Stimuli Restore Biliary Drainage by Promoting Hepatobiliary Remodeling in a Rat Model.

Authors:  Beate Richter; Constanze Sänger; Franziska Mussbach; Hubert Scheuerlein; Utz Settmacher; Uta Dahmen
Journal:  Front Surg       Date:  2022-04-25

3.  To Systematically Evaluate and Analyze the Efficacy and Safety of Transcatheter Arterial Chemoembolization (TACE) in the Treatment of Primary Liver Cancer.

Authors:  Xiao Yang; Tingting Lan; Hui Zhong; Zujian Zhang; Hui Xie; Youwei Li; Wen Huang
Journal:  J Healthc Eng       Date:  2022-03-21       Impact factor: 2.682

4.  Predictive Factors for Hypertrophy of the Future Liver Remnant After Portal Vein Embolization: A Systematic Review.

Authors:  E A Soykan; B M Aarts; M Lopez-Yurda; K F D Kuhlmann; J I Erdmann; N Kok; K P van Lienden; E A Wilthagen; R G H Beets-Tan; O M van Delden; F M Gomez; E G Klompenhouwer
Journal:  Cardiovasc Intervent Radiol       Date:  2021-06-17       Impact factor: 2.740

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.